Live Price
Live Volume
Chart Volume 0
Volume 0
5 secRevelation Biosciences Market Segments
After Hours
+0.00(+0.00%)
| Open | $3.54 |
|---|---|
| Close | $3.54 |
| Low | $3.54 |
| Low Change | 0.00 (0.00%) |
| High | $3.54 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 146 |
| Dollar Volume | $516.11 |
Regular Trading Hours
-0.23(-5.98%)
| Open | $3.76 |
|---|---|
| Close | $3.54 |
| Low | $3.36 |
| Low Change | -0.40 (-10.64%) |
| High | $3.87 |
| High Change | +0.11 (+2.93%) |
| Range | $0.51 |
| Volume | 8.832K |
| Dollar Volume | $31.22K |
Premarket
*No Trades in Segment
Overnight
*No Trades in Segment
After Hours Yesterday
*No Trades in Segment
Regular Trading Hours Yesterday
+0.11(+2.99%)
| Open | $3.68 |
|---|---|
| Close | $3.79 |
| Low | $3.66 |
| Low Change | -0.02 (-0.54%) |
| High | $3.88 |
| High Change | +0.20 (+5.43%) |
| Range | $0.22 |
| Volume | 15.154K |
| Dollar Volume | $57.43K |
Premarket Yesterday
*No Trades in Segment
Revelation Biosciences News
Revelation Biosciences Top Trades
Revelation Biosciences's top trade so far today returned +5.21%, while the top short trade returned -10.64%.
Revelation Biosciences Moving Averages
| 5 Day Moving Average (SMA5) | $3.04 |
|---|---|
| 10 Day Moving Average (SMA10) | $1.87 |
| 20 Day Moving Average (SMA20) | $1.33 |
| 50 Day Moving Average (SMA50) | $1.13 |
| 100 Day Moving Average (SMA100) | $1.09 |
| 200 Day Moving Average (SMA200) | $1.31 |
Revelation Biosciences Statistics
| Average Volume (30 Days) | 31.94K |
|---|---|
| P/E Ratio (Current) | -.16 |
| EPS (Current) | -$4.82 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$9.44M |
| Cash Ratio | 6.11 |
| Current Ratio | 6.21 |
| Quick Ratio | 6.21 |
| Debt to Equity | 0.00 |
| Enterprise Value | -$8.46M |
| EV to EBITDA | 0.75 |
| EV to Sales | — |
| Price to Book | 0.30 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -1.54% |
| Return on Equity | -1.91% |
Revelation Biosciences Stock Splits
There have been 5 stock splits for Revelation Biosciences (REVB). The last reverse stock split occured on January 28, 2026 and reduced the outstanding shares at a ratio of 4:1.
| Date | Type | Ratio |
|---|---|---|
| Jan 28, 2026 | Reverse | 4:1 |
| Jul 7, 2025 | Reverse | 3:1 |
| Jan 28, 2025 | Reverse | 16:1 |
| Jan 25, 2024 | Reverse | 30:1 |
| Feb 1, 2023 | Reverse | 35:1 |
Revelation Biosciences Dividends
There have been no dividends for Revelation Biosciences (REVB).